Liang, Li
Peking University Third Hospital
3 papers on CoChatORCID 0000-0002-1694-380X
Most cited papers
- Verified
PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis
Tuo, L., Xiang, J., Pan, X., Hu, J., Tang, H., Liang, L., Xia, J., Hu, Y., Zhang, W., Huang, A., et al. (2019) · Journal of Experimental & Clinical Cancer Research
Metabolism, Diabetes, and CancerCancer, Hypoxia, and Metabolism
Cited by 84
- Verified
Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression
Duan, Y., Tian, L., Gao, Q., Liang, L., Zhang, W., Yang, Y., Zheng, Y., Pan, E., Li, S., & Tang, N. (2016) · Oncotarget
Chromatin Remodeling and CancerHepatocellular Carcinoma Treatment and Prognosis
Cited by 50
- Verified
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): 4-year outcomes from a double-blind, randomised, phase 3 trial
Zhou, C., Wang, Z., Sun, M., Cao, L., Ma, Z., Wu, R., Yu, Y., Yao, W., Sun, S., Chen, J., et al. (2025) · The Lancet Oncology
Lung Cancer Treatments and MutationsCancer Immunotherapy and Biomarkers
Cited by 23
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free